Comparison between Reference Infliximab (Remicade) and its Biosimilar (Remsima) in Patients with Ankylosing Spondylitis: A Field-based Pharmacoeconomic Study
Background: Ankylosing spondylitis is a chronic inflammatory disease that mostly involves the spine and sacroiliac joints. It is associated with a decreased quality of life. Biological medicines such as infliximab and its biosimilar are the mainstay treatments for active ankylosing spondylitis. O...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
University of Baghdad/ Al-Kindy College of Medicine
2023-04-01
|
Series: | مجله كليه طب الكندي |
Subjects: | |
Online Access: | https://jkmc.uobaghdad.edu.iq/index.php/MEDICAL/article/view/908 |